These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3736675)

  • 1. [Cytostatic platinum complexes: an unexpected discovery with considerable consequences].
    Köpf-Maier P; Köpf H
    Naturwissenschaften; 1986 May; 73(5):239-47. PubMed ID: 3736675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non platinum metal complexes as anti-cancer drugs.
    Ott I; Gust R
    Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.
    Pratesi G; Perego P; Polizzi D; Righetti SC; Supino R; Caserini C; Manzotti C; Giuliani FC; Pezzoni G; Tognella S; Spinelli S; Farrell N; Zunino F
    Br J Cancer; 1999 Aug; 80(12):1912-9. PubMed ID: 10471039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Viale M; Cafaggi S; Parodi B; Esposito M
    Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Structure-activity relations of antineoplastic platinum II and platinum IV coordination compounds].
    Gutsche W; Baumgart J; Schröer HP
    Arch Geschwulstforsch; 1989; 59(4):233-8. PubMed ID: 2802931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.
    Frühauf S; Zeller WJ
    Cancer Res; 1991 Jun; 51(11):2943-8. PubMed ID: 2032232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment.
    Zhao G; Lin H
    Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):137-47. PubMed ID: 15777221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M; Balázová E; Ujházy V
    Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytostatic non-platinum metal complexes: new perspectives for the treatment of cancer?].
    Köpf-Maier P
    Naturwissenschaften; 1987 Aug; 74(8):374-82. PubMed ID: 3309682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Komeda S
    Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organo-platinum complexes as antitumor agents (review).
    Hill JM; Speer RJ
    Anticancer Res; 1982; 2(3):173-86. PubMed ID: 6751211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antitumor platinum complexes].
    Kidani Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2442-52. PubMed ID: 6360050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New platinum agents. A comparison in ovarian cancer.
    Kelland LR; McKeage MJ
    Drugs Aging; 1994 Aug; 5(2):85-95. PubMed ID: 7981487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between proteins and platinum-containing anti-cancer drugs.
    Bischin C; Lupan A; Taciuc V; Silaghi-Dumitrescu R
    Mini Rev Med Chem; 2011 Mar; 11(3):214-24. PubMed ID: 21534930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.